POSTER SESSION V
Wednesday, March 11, 2009 — 9:30 AM - 12:00 Noon
Convention Center Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
166
Complete Absence of KSHV/HHV8 in Post-Transplant Lymphoproliferative Disorders: An Immunohistochemical and Molecular Study of 52 Cases
(1176)
W Chen, Q Huang, CW Zuppan, EH Rowsell, JD Cao, LM Weiss, J Wang - City of Hope National Medical Center, Duarte, CA; Loma Linda University Medical Center, Loma Linda, CA; Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Early-Onset, EBV-Negative PTLD in Pediatric Solid Organ Transplant Recipients: Spectrum of Plasma Cell Neoplasms with Favorable Prognosis
(1264)
A Morovic, DW Coulter, W Sanger, PF Coccia, P Aoun - University of Nebraska, Medical Center, Omaha, NE
Uniform Expression of Notch1, Suppressor of B-Cell Specific Gene Expression, in Plasmablastic Lymphoma
(1292)
AC Seegmiller, A Maleki, W Kabbani, P Shang, HY Wang, W Chen - UT Southwestern Medical Center, Dallas, TX
Notch 1 in Primary Effusion Lymphoma: A Clinicopathologic Study
(1310)
HY Wang, F Fuda, NJ Karandikar - UT Southwestern Medical Center at Dallas, Dallas, TX
Activation of mTORC1 Signaling Pathway in AIDS-Related Lymphomas
(1189)
M El-Salem, PN Raghunath, M Marzec, M Kasprzycka, X Liu, MA Wasik - University of Pennsylvania, Philadelphia, PA
MYC Gene Copy Increase Is Common in Diffuse Large B-Cell Lymphoma
(1300)
CJ Stasik, H Nitta, JR Cook, RR Tubbs, TM Grogan, LM Rimsza - University of Arizona, Tucson, AZ; Ventana Medical Systems, Inc., Tucson, AZ; Cleveland Clinic, Cleveland, OH
Dual Color Chromogenic In Situ Hybridization Is a Rapid, Specific and Sensitive Method for Identifying MYC Translocations in Paraffin-Embedded Tissue
(1242)
ME Law, A Dogan, ED Remstein - Mayo Clinic, Rochester, MN
A Novel Flow Cytometric Antibody Panel for Distinguishing Burkitt Lymphoma from CD10-Positive Diffuse Large B-Cell Lymphoma
(1290)
SD Schniederjan, S Li, MJ Lechowicz, DF Saxe, PD Terry, KP Mann - Emory University School of Medicine, Atlanta; Winship Cancer Institute, Emory University School of Medicine, Atlanta; Rollins School of Public Health, Emory University, Atlanta, GA
Phospho-p70s6k and cdc2/cdk1 Are Associated with Diffuse Large B-Cell Lymphoma and Are Potential Targets for Combination Chemotherapy
(1325)
MY Zhao, A Auerbach, AD Costa, AP Rapoport, AM Burger, F Jiang, SA Stass, AK Sands, N Aguilera, EA Sausville, XF Zhao - University of Maryland School of Medicine, Baltimore, MD; Armed Forces Institute of Pathology, Washington, DC; University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD; University at Buffalo, SUNY, Buffalo, NY
Sonic Hedgehog Signaling Pathway as a Therapeutic Target in Diffuse Large B-Cell Lymphoma
(1230)
JE Kim, RR Singh, C Milito, JH Cho-Vega, M Karanikou, F Kasbidi, LJ Medeiros, R Luthra, F Vega - MD Anderson Cancer Center, Houston, TX
MGMT in Primary Nodal Diffuse Large B-Cells Lymphomas: Immunohistochemical Expression and Methylation Status
(1306)
S Uccella, C Placidi, S Marchet, R Cerutti, I Carnevali, D Furlan, G Pinotti, C Capella - University of Insubria - Ospedale di Circolo, Varese, Italy; Ospedale di Circolo, Varese, Italy
Prognostic Impact of Immunohistochemical Profile and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with R-CHOP
(1167)
T Cardesa, G Gutierrez-Garcia, F Climent, L Arenillas, S Serrano, V Romagosa, E Gonzalez-Barca, E Campo, A Lopez-Guillermo, Ll Colomo - Hospital Clínic, Barcelona, Spain; Hospital de Bellvitge, Barcelona, Spain; Hospital del Mar, Barcelona, Grup Estudi Limfomes Catalunya i Balears, Spain
LMO2 Expression and the Hans Algorithm in Predicting Germinal Center Phenotype and Survival in Diffuse Large B-Cell Lymphoma Treated with Rituximab
(1258)
PN Meyer, DD Weisenburger, WL Choi, LM Smith, TC Greiner, P Aoun, J Delabie, RM Braziel, JM Vose, G Lenz, LM Staudt, WC Chan, K Fu - University of Nebraska Medical Center, Omaha, NE; University of Hong Kong Faculty of Medicine, Hong Kong, China; University of Oslo Medical Center, Oslo, Norway; Oregon Health and Science University, Portland, OR; National Cancer Institute, Bethesda, MD
Comparison of AIDS-Related Diffuse Large B-Cell Lymphomas and Immunocompetent DLBCLs Suggest Biologic Differences
(1170)
A Chadburn, S Silver, L Pasqualucci, R Dalla-Favera, K Merati, M McGrath, L Ayers, JM Orenstein, DM Knowles, E Cesarman - Pathology & Laboratory Medicine, Weill Cornell Medical College; George Washington University, University of California-San Francisco, Ohio State University; Pathology & Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University; Acupath Laboratories, Plainview, NY
Distinct Cytogenetic Profiles of Diffuse Large B-Cell Lymphoma in Chinese and Western Population
(1178)
Y Chen, BJ Dave, X Zhu, WC Chan, R Irons, K Fu - University of Nebraska Medical Center, Omaha, NE; Shanghai Cancer Hospital, Shanghai, China; Fudan University, Shanghai, China
Biased Immunoglobulin VH Recombination and Increased Expression of Chemokine Receptor XCR1 Are Distinct Features of Bone Marrow-Derived Diffuse Large B-Cell Lymphoma
(1320)
Y Yamashita, D Kajiura, S Nakamura, S Toyokuni, N Mori - Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Nagoya University Hospital, Nagoya, Aichi, Japan
B-Cell Neoplasms with Aberrant T-Cell Antigen Expression Show Plasmacytic Differentiation
(1210)
JL Herrick, KL Grogg, WR Macon, A Dogan, AL Feldman - Mayo Clinic College of Medicine, Rochester, MN
Arsenic Trioxide/IFN- a Combination Eradicated ATLL in SCID Mice: A Focus on Morphology
(1285)
ST Saab, H El Hajj, A Bazarbachi, G Zaatari - American University of Beirut, Beirut, Lebanon
JunB Oncogenic Activity in Anaplastic Large Cell Lymphoma
(1158)
V Atsaves, L Lekakis, M Feretzaki, V Leventaki, C Liakou, E Drakos, FX Claret, D Jones, LJ Medeiros, E Patsouris, GZ Rassidakis - The University of Texas M.D. Anderson Cancer Center, Houston, TX; National and Kapodistrian University of Athens, Athens, Greece
Oncogenic Kinase NPM/ALK Induces Immunosuppressive Protein CD274 (PD-LI, B7-H1) through STAT3 Expression
(1198)
A Goradia, M Marzec, Q Zhang, P Raghunath, X Liu, M Paessler, H Wang, M Wysocka, M Wasik - Hospital of the University of Pennsylvania, Philadelphia, PA
Assessing Clonality and Disease Burden of T-Cell Large Granular Lymphocyte Leukemia by TCR-V b Flow Cytometric Analysis
(1192)
B Feng, JL Jorgensen, LJ Medeiros, SA Wang - UT MD Anderson Cancer Center, Houston, TX
Detection of Monoclonal B-Cell Lymphocytoses by Flow Cytometry in Patients with T-Cell Large Granular Lymphocyte Leukemia
(1213)
MT Howard, J Maciejewski, ED Hsi - Cleveland Clinic, Cleveland, OH
Clonal T-Cell Receptor Gene Rearrangements in Traumatic Ulcerative Granuloma with Stromal Eosinophilia
(1238)
CL Kossover, S Budnick, S Li - Emory University, Atlanta, GA
EBV-Associated T/NK-Cell Lymphoproliferative Disorders in Children and Adolescents: A Clinicopathologic and Molecular Study of 10 Cases
(1312)
S Wang, SEC Quek, B Mow, WJ Chng, A Yeoh, TC Quah, PL Tan, SB Ng - National University Hospital, Singapore, Singapore; King's College, London, United Kingdom
Most Primary Intestinal T and NK/T-Cell Lymphoma in Taiwan Are Unspecified Peripheral T-Cell Lymphomas Showing Cytotoxic Phenotype, and NK Lineage and Perforation Predict Poor Survival
(1181)
S-S Chuang, S-T Chang, W-T Huang, P-P Hsieh, M-H Tsou, Y-C Jung - Chi-Mei Medical Center, Tainan, Taiwan; Chang Gung Memorial Hospital-Kaohsiung, Kaohsiung, Taiwan; Veterans General Hospital-Kaohsiung, Kaohsiung, Taiwan; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan; Sin-Lau Christian Hospital, Tainan, Taiwan
Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma Expresses Follicular T-Cell Markers
(1282)
SM Rodriguez-Pinilla, G Roncador, JL Rodriguez-Peralto, M Mollejo, JF Garcia, S Montes-Moreno, FI Camacho, P Ortiz, MA Limeres-Gonzalez, A Torres, E Campo, P Navarro-Conde, MA Piris - CNIO, Madrid, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital de Gran Canaria, Gran Canaria, Spain; Hospital Rio Hortega, Valladolid, Spain; Hospital Clinic, Barcelona, Spain; Hospital Arnau de Vilanova, Valencia, Spain
Angioimmunoblastic T-Cell Lymphoma with Hyperplastic Germinal Centres (Pattern I): Clinicopathological and Immunohistochemical Study of 10 Cases
(1281)
M Rodriguez-Justo, A Attygalle, P Munson, G Roncador, MA Piris - University College London Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Spanish National Cancer Centre, Madrid, Spain
Characterization of TCR d Expression in Paraffin Embedded Tissue Sections: A New Diagnostic Tool for gd T-Cell Lymphomas
(1195)
A Garcia, N Villamor, P Gaulard, E Jaffe, E Campo, A Martinez - Hospital Clinic, Barcelona, Spain; Hospital Henri Mondor, Creteil, France; National Cancer Institute, Bethesda, md
The Density of Regulatory FOXP3+ T-Cells Is Associated with Caspase-3 Activation in Hodgkin/Reed-Sternberg Cells of Classical Hodgkin Lymphoma
(1186)
E Drakos, GZ Rassidakis, EJ Schlette, TP Vassilakopoulos, C Kittas, AH Sarris, LJ Medeiros - The University of Texas M.D. Anderson Cancer Center, Houston, TX; National and Kapodistrian University of Athens, Athens, Greece; Hygeia Hospital, Athens, Greece
Analyses of Micro-RNA Expression in Classical Hodgkin Lymphoma Tumors
(1288)
B Sanchez-Espiridion, J Alves-ferreira, M Canales, ME Rodriguez, MM Morente, MA Piris, JF Garcia - Spanish National Cancer Centre, Madrid, Spain; Hospital La Paz, Madrid, Spain; MD Anderson International, Madrid, Spain
Expression of Survival Signals of Endoplasmic Reticulum Stress in Hodgkin Lymphoma
(1173)
KC Chang, WC Chen, YT Jin, PCH Chen, D Jones - National Cheng Kung University, Tainan, Taiwan; Veterans General Hospital-Taipei, Taipei, Taiwan; University of Texas M.D. Anderson Cancer Center, Houston, TX
Role of Macrophage Migration Inhibitory Factor in Hodgkin Lymphoma
(1235)
MJ Kluk, KM Hoyt, C Bifulco - Massachusetts General Hospital, Boston, MA; Yale New Haven Hospital, New Haven, CT
Assessment of Bone Marrow Plasma Cells by Flow Cytometry, Fluorescence In Situ Hybridization, and Bone Marrow Morphology in 224 Cases for Diagnosis of Plasma Cell Neoplasms
(1248)
G Lu, WR Stull, W Chen, XX Zhang - UT MD Anderson Cancer Center, Houston, TX; Medical Laboratory Services, Murrieta, CA; USLabs, Irvine, CA
Classification of Amyloidosis in Fat Aspiration Specimens Using Mass Spectrometry Based Proteomics
(1307)
JA Vrana, SR Zeldenrust, JD Theis, JD Gamez, PJ Kurtin, A Dogan - Mayo Clinic, Rochester, MN
Amyloidogenic Nature of Circulating Transthyretin Variants, V122I and V30A, and the Effect of the NSAID, Diflunisal
(1200)
MJ Greene, K Laporte, E Klimtchuk, D Seldin, LH Connors - Boston University School of Medicine, Boston, MA; BUSM, Boston, MA
CD20-Positive Multiple Myeloma: A Subtype Associated with a Worse Prognostic Profile
(1232)
S Kitahara, A Yung, R Alsabeh - Cedars-Sinai Medical Center, Los Angeles, CA
MUM1 and CD138 Immunophenotype as Prognostic Markers in Patients with Multiple Myeloma
(1225)
A Junger, C Fibich, M Voralia, H Neufeld, H Doell, SK Verma, JF DeCoteau, EE Torlakovic - College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada; Saskatchewan Cancer Agency, Saskatoon, SK, Canada
Light Chain Only Plasma Cell Dyscrasias Demonstrate Increased Bone Marrow Microvessel Density and Mast Cells
(1221)
JR Jacobsen, GJ Stoddard, SR Tripp, SL Perkins, TW Kelley - University of Utah & ARUP Laboratories, Salt Lake City, UT; University of Utah School of Medicine, Salt Lake City, UT
Plasma Cell Myeloma with MYC Rearrangement Involving Immunoglobulin Genes
(1155)
M Almiski, A Maleki, R Garcia, W Chen - UT Southwestern Medical Center at Dallas, Dallas, TX
CD23 Expression in Plasma Cell Myeloma Is Specific for Abnormalities of Chromosome 11, and Is Associated with Primary Plasma Cell Leukemia in This Cytogenetic Sub-Group
(1309)
MP Walters, H Olteanu, P Van Tuinen, SH Kroft - Medical College of Wisconsin, Milwaukee, WI
Multiple Myeloma Patients with 13q14 Deletion Show a Significant Downregulation of MicroRNA Gene Mir16a but Not of Mir15a
(1251)
A Malik, SU Bozkurt, AA Toor, S Alkan - Loyola University Medical Center, Maywood, IL
Anaplastic Multiple Myeloma Is Associated with High-Risk Molecular Cytogenetic Abnormalities
(1229)
DT Kim, H Chang - University Health Network and University of Toronto, Toronto, Canada
Nutlin-3 and Velcade Synergistically Induce Cell Cycle Arrest and Apoptosis in Multiple Myeloma through Activation of p53 Pathway
(1287)
MN Saha, J Jayakar, H Chang - University Health Network and University of Toronto, Toronto, Canada
button next to any title to add to Itinerary Planner...
Add
